BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29692244)

  • 1. Inhibition of Chlamydia trachomatis Growth During the Last Decade: A Mini-Review.
    Serradji N; Vu TH; Kim H; Panyam J; Verbeke P
    Mini Rev Med Chem; 2018; 18(16):1363-1372. PubMed ID: 29692244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia trachomatis infection and veneral disease.
    Johannisson G; Edmar B; Lycke E
    Acta Derm Venereol; 1977; 57(5):455-8. PubMed ID: 73314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infections with Chlamydia trachomatis].
    Stock I; Henrichfreise B
    Med Monatsschr Pharm; 2012 Jun; 35(6):209-22; quiz 223-4. PubMed ID: 22808665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genital chlamydial infections].
    Schwarz T; Gschnait F
    Wien Klin Wochenschr; 1986 Jun; 98(13):405-10. PubMed ID: 3755852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexually transmitted Chlamydia trachomatis.
    Ferreira N
    Nurse Pract Forum; 1997 Jun; 8(2):70-6. PubMed ID: 9325898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia trachomatis--clinical significance and strategies of intervention.
    Weström LV
    Semin Dermatol; 1990 Jun; 9(2):117-25. PubMed ID: 2202407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis infections: screening, diagnosis, and management.
    Mishori R; McClaskey EL; WinklerPrins VJ
    Am Fam Physician; 2012 Dec; 86(12):1127-32. PubMed ID: 23316985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the treatment of Chlamydia trachomatis infection].
    Shi LL; Lu JC; Huangfu YM
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):296-8. PubMed ID: 15921264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials.
    Shima K; Kaufhold I; Eder T; Käding N; Schmidt N; Ogunsulire IM; Deenen R; Köhrer K; Friedrich D; Isay SE; Grebien F; Klinger M; Richer BC; Günther UL; Deepe GS; Rattei T; Rupp J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chlamydia trachomatis infections].
    Széll A; Szalka A
    Orv Hetil; 1998 Nov; 139(46):2767-73. PubMed ID: 9849062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CtHtrA: the lynchpin of the chlamydial surface and a promising therapeutic target.
    Marsh JW; Ong VA; Lott WB; Timms P; Tyndall JD; Huston WM
    Future Microbiol; 2017 Jul; 12():817-829. PubMed ID: 28593794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of antiseptics on Chlamydia trachomatis growth.
    Párducz L; Eszik I; Wagner G; Burián K; Endrész V; Virok DP
    Lett Appl Microbiol; 2016 Oct; 63(4):260-7. PubMed ID: 27472980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which treatment for genital tract Chlamydia trachomatis infection?
    Tobin JM; Harindra V; Mani R
    Int J STD AIDS; 2004 Nov; 15(11):737-9. PubMed ID: 15537459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antibiotic treatment on active trachoma and ocular Chlamydia trachomatis infection.
    Mabey D; Solomon A
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):209-16. PubMed ID: 15482115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host defense peptides: general overview and an update on their activity against Chlamydia spp.
    Di Francesco A; Favaroni A; Donati M
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1215-24. PubMed ID: 24111488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel protease inhibitor causes inclusion vacuole reduction and disrupts the intracellular growth of Chlamydia trachomatis.
    Zhou Y; Lu X; Huang D; Lu Y; Zhang H; Zhang L; Yu P; Wang F; Wang Y
    Biochem Biophys Res Commun; 2019 Aug; 516(1):157-162. PubMed ID: 31202460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chlamydia infections in gynecology and obstetrics].
    Steigerwald U; Strobel E
    Fortschr Med; 1995 May; 113(14):205-6. PubMed ID: 7607588
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a strong and specific antichlamydial N-acylhydrazone.
    Zhang H; Kunadia A; Lin Y; Fondell JD; Seidel D; Fan H
    PLoS One; 2017; 12(10):e0185783. PubMed ID: 28973037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.